TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE
Product details
Registration number: SIN16815P
Classification: Prescription Only
Active ingredients: Tezepelumab
Strength: 210 mg/unit
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: ASTRAZENECA SINGAPORE PTE LTD
ATC code: R03DX11
HSA approval date: 4 July 2023
Manufacturer(s): Amgen Manufacturing Limited LLC
Manufacturing country/countries: UNITED STATES
What are the HSA registration number and classification for TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16815P
Classification: Prescription Only
What active ingredients and strength are recorded for TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Tezepelumab
Strength: 210 mg/unit
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTRAZENECA SINGAPORE PTE LTD
Which manufacturers and countries are listed for TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Amgen Manufacturing Limited LLC
Manufacturing country/countries: UNITED STATES
Where can I look up TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16815P or the exact product name TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE. The general register link does not preselect this product.
What are the source dates for this TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16815P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)